Try our beta test site
11 studies found for:    Ipatasertib OR GDC-0068
Show Display Options
Rank Status Study
1 Completed Ipatasertib (GDC-0068) Study to Evaluate Formulation Change and Food Effect on Bioavailability in Healthy Subjects
Condition: Cancer
Interventions: Drug: Ipatasertib (capsule);   Drug: Ipatasertib (tablet)
2 Recruiting A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Patients With Early Stage Triple Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Ipatasertib;   Drug: Paclitaxel;   Drug: Placebo
3 Active, not recruiting A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors
Condition: Breast Neoplasms
Interventions: Drug: Ipatasertib;   Drug: Paclitaxel;   Drug: Placebo
4 Completed
Has Results
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors
Condition: Neoplasms
Interventions: Drug: Ipatasertib;   Drug: Cobimetinib
5 Completed A Study Evaluating the Effect of Formulation on the Bioavailability of Ipatasertib in Healthy Volunteers
Condition: Healthy Volunteer
Interventions: Drug: ipatasertib (Capsule);   Drug: ipatasertib (Tablet)
6 Completed A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors
Condition: Solid Cancers
Intervention: Drug: GDC-0068
7 Completed A Phase I Bioavailability and Pharmacokinetic Study of [14C]-Ipatasertib Single Oral and Intravenous Doses in Healthy Male Subjects
Condition: Healthy Volunteer
Interventions: Drug: Period 1 treatment;   Drug: Period 2 treatment
8 Active, not recruiting A Study of GDC-0068 in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer
Condition: Gastric Cancer
Interventions: Drug: 5-Fluorouracil;   Drug: GDC-0068;   Drug: Leucovorin;   Drug: Oxaliplatin;   Drug: Placebo
9 Active, not recruiting Safety and Pharmacology Of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Patients With Advanced Solid Tumors
Condition: Solid Cancers
Interventions: Drug: GDC-0068;   Drug: docetaxel;   Drug: enzalutamide;   Drug: mFOLFOX6;   Drug: paclitaxel
10 Active, not recruiting Study of GDC-0068 Or GDC-0980 With Abiraterone Acetate Versus Abiraterone Acetate in Patients With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy
Condition: Prostate Cancer
Interventions: Drug: GDC-0068;   Drug: GDC-0980;   Drug: abiraterone;   Drug: placebo;   Drug: prednisone
11 Enrolling by invitation Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475
Condition: Glioblastoma
Interventions: Drug: MK - 3475;   Biological: Suppressor of the PI3K/Akt pathways

Study has passed its completion date and status has not been verified in more than two years.